<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wijeyesekera A</submitter><funding>NHLBI NIH HHS</funding><pagination>65-72</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3740387</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>4(1)</volume><pubmed_abstract>The role of the gut microbiome in human health, and non-invasive measurement of gut dysbiosis are of increasing clinical interest. New high-throughput methods are required for the rapid measurement of gut microbial metabolites and to establish reference ranges in human populations. We used ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) -- positive and negative electrospray ionization modes, multiple reaction monitoring transitions -- to simultaneously measure three urinary metabolites (phenylacetylglutamine, 4-cresyl sulphate and hippurate) that are potential biomarkers of gut function, among multi-ethnic US men and women aged 40-59 from the INTERMAP epidemiologic study (n = 2000, two timed 24-hr urine collections/person). Metabolite concentrations were quantified via stable isotope labeled internal standards. The assay was linear in the ranges 1ng/mL (lower limit of quantification) to 1000ng/mL (phenylacetylglutamine and 4-cresyl sulfate) and 3ng/mL to 3000ng/mL (hippurate). These quantitative data provide new urinary reference ranges for population-based human samples: mean (standard deviation) 24-hr urinary excretion for phenylacetylglutamine was: 1283.0 (751.7) ?mol/24-hr (men), 1145.9 (635.5) ?mol/24-hr (women); for 4-cresyl sulphate, 1002.5 (737.1) ?mol/24-hr (men), 1031.8 (687.9) ?mol/24-hr (women); for hippurate, 6284.6 (4008.1) ?mol/24-hr (men), 4793.0 (3293.3) ?mol/24-hr (women). Metabolic profiling by UPLC-MS/MS in a large sample of free-living individuals has provided new data on urinary reference ranges for three urinary microbial co-metabolites, and demonstrates the applicability of this approach to epidemiological investigations.</pubmed_abstract><journal>Analytical methods : advancing methods and applications</journal><pubmed_title>Quantitative UPLC-MS/MS analysis of the gut microbial co-metabolites phenylacetylglutamine, 4-cresyl sulphate and hippurate in human urine: INTERMAP Study.</pubmed_title><pmcid>PMC3740387</pmcid><funding_grant_id>R01 HL084228</funding_grant_id><funding_grant_id>R01 HL050490</funding_grant_id><pubmed_authors>Stamler J</pubmed_authors><pubmed_authors>Wijeyesekera A</pubmed_authors><pubmed_authors>Clarke PA</pubmed_authors><pubmed_authors>Yap IK</pubmed_authors><pubmed_authors>Ryckmans T</pubmed_authors><pubmed_authors>Brown IJ</pubmed_authors><pubmed_authors>Chan Q</pubmed_authors><pubmed_authors>Holmes E</pubmed_authors><pubmed_authors>Elliott P</pubmed_authors><pubmed_authors>Bictash M</pubmed_authors><pubmed_authors>Fidock M</pubmed_authors><pubmed_authors>Nicholson JK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Quantitative UPLC-MS/MS analysis of the gut microbial co-metabolites phenylacetylglutamine, 4-cresyl sulphate and hippurate in human urine: INTERMAP Study.</name><description>The role of the gut microbiome in human health, and non-invasive measurement of gut dysbiosis are of increasing clinical interest. New high-throughput methods are required for the rapid measurement of gut microbial metabolites and to establish reference ranges in human populations. We used ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) -- positive and negative electrospray ionization modes, multiple reaction monitoring transitions -- to simultaneously measure three urinary metabolites (phenylacetylglutamine, 4-cresyl sulphate and hippurate) that are potential biomarkers of gut function, among multi-ethnic US men and women aged 40-59 from the INTERMAP epidemiologic study (n = 2000, two timed 24-hr urine collections/person). Metabolite concentrations were quantified via stable isotope labeled internal standards. The assay was linear in the ranges 1ng/mL (lower limit of quantification) to 1000ng/mL (phenylacetylglutamine and 4-cresyl sulfate) and 3ng/mL to 3000ng/mL (hippurate). These quantitative data provide new urinary reference ranges for population-based human samples: mean (standard deviation) 24-hr urinary excretion for phenylacetylglutamine was: 1283.0 (751.7) ?mol/24-hr (men), 1145.9 (635.5) ?mol/24-hr (women); for 4-cresyl sulphate, 1002.5 (737.1) ?mol/24-hr (men), 1031.8 (687.9) ?mol/24-hr (women); for hippurate, 6284.6 (4008.1) ?mol/24-hr (men), 4793.0 (3293.3) ?mol/24-hr (women). Metabolic profiling by UPLC-MS/MS in a large sample of free-living individuals has provided new data on urinary reference ranges for three urinary microbial co-metabolites, and demonstrates the applicability of this approach to epidemiological investigations.</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012 Jan</publication><modification>2021-02-21T01:06:42Z</modification><creation>2019-03-27T01:14:25Z</creation></dates><accession>S-EPMC3740387</accession><cross_references><pubmed>23946767</pubmed><doi>10.1039/C1AY05427A</doi><doi>10.1039/c1ay05427a</doi></cross_references></HashMap>